Susanne Haga
Professor, Duke University
Research Expertise
About
Publications
Reconsidering the family history in primary care
Journal of General Internal Medicine / Mar 01, 2004
Rich, E. C., Burke, W., Heaton, C. J., Haga, S., Pinsky, L., Short, M. P., & Acheson, L. (2004). Reconsidering the family history in primary care. Journal of General Internal Medicine, 19(3), 273–280. https://doi.org/10.1111/j.1525-1497.2004.30401.x
Primary care physicians' knowledge of and experience with pharmacogenetic testing
Clinical Genetics / Jul 03, 2012
Haga, S., Burke, W., Ginsburg, G., Mills, R., & Agans, R. (2012). Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clinical Genetics, 82(4), 388–394. Portico. https://doi.org/10.1111/j.1399-0004.2012.01908.x
Public Knowledge of and Attitudes Toward Genetics and Genetic Testing
Genetic Testing and Molecular Biomarkers / Apr 01, 2013
Haga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. (2013). Public Knowledge of and Attitudes Toward Genetics and Genetic Testing. Genetic Testing and Molecular Biomarkers, 17(4), 327–335. https://doi.org/10.1089/gtmb.2012.0350
Genomic profiling to promote a healthy lifestyle: not ready for prime time
Nature Genetics / Aug 01, 2003
Haga, S. B., Khoury, M. J., & Burke, W. (2003). Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nature Genetics, 34(4), 347–350. https://doi.org/10.1038/ng0803-347
Ethical, Legal, and Social Implications of Biobanks for Genetics Research
Genetic Dissection of Complex Traits / Jan 01, 2008
Haga, S. B., & Beskow, L. M. (2008). Ethical, Legal, and Social Implications of Biobanks for Genetics Research. In Advances in Genetics (pp. 505–544). Elsevier. https://doi.org/10.1016/s0065-2660(07)00418-x
Survey of US public attitudes toward pharmacogenetic testing
The Pharmacogenomics Journal / Feb 15, 2011
Haga, S. B., O’Daniel, J. M., Tindall, G. M., Lipkus, I. R., & Agans, R. (2011). Survey of US public attitudes toward pharmacogenetic testing. The Pharmacogenomics Journal, 12(3), 197–204. https://doi.org/10.1038/tpj.2011.1
Handbook of Human Tissue Sources: A National Resource of Human Tissue Samples
Jan 01, 1999
Handbook of Human Tissue Sources: A National Resource of Human Tissue Samples. (1999). RAND Corporation. https://doi.org/10.7249/mr954
Impact of limited population diversity of genome-wide association studies
Genetics in Medicine / Feb 01, 2010
Haga, S. B. (2010). Impact of limited population diversity of genome-wide association studies. Genetics in Medicine, 12(2), 81–84. https://doi.org/10.1097/gim.0b013e3181ca2bbf
Insurance Coverage Policies for Personalized Medicine
Journal of Personalized Medicine / Oct 30, 2012
Hresko, A., & Haga, S. (2012). Insurance Coverage Policies for Personalized Medicine. Journal of Personalized Medicine, 2(4), 201–216. https://doi.org/10.3390/jpm2040201
Primary Care Physicians’ Knowledge, Attitudes, and Experience with Personal Genetic Testing
Journal of Personalized Medicine / May 24, 2019
Haga, S. B., Kim, E., Myers, R. A., & Ginsburg, G. S. (2019). Primary Care Physicians’ Knowledge, Attitudes, and Experience with Personal Genetic Testing. Journal of Personalized Medicine, 9(2), 29. https://doi.org/10.3390/jpm9020029
BP1, a new homeobox gene, is frequently expressed in acute leukemias
Leukemia / Nov 01, 2000
Haga, S., Fu, S., Karp, J., Ross, D., Williams, D., Hankins, W., Behm, F., Ruscetti, F., Chang, M., Smith, B., Becton, D., Raimondi, S., & Berg, P. (2000). BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia, 14(11), 1867–1875. https://doi.org/10.1038/sj.leu.2401912
Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists
Pharmacogenomics / Jun 01, 2013
Mills, R., & Haga, S. B. (2013). Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics, 14(8), 957–968. https://doi.org/10.2217/pgs.13.76
Public Perspectives on Returning Genetics and Genomics Research Results
Public Health Genomics / Jan 01, 2011
O’Daniel, J., & Haga, S. B. (2011). Public Perspectives on Returning Genetics and Genomics Research Results. Public Health Genomics, 14(6), 346–355. Portico. https://doi.org/10.1159/000324933
Translating genomic biomarkers into clinically useful diagnostics
Expert Review of Molecular Diagnostics / Mar 01, 2006
Ginsburg, G. S., & Haga, S. B. (2006). Translating genomic biomarkers into clinically useful diagnostics. Expert Review of Molecular Diagnostics, 6(2), 179–191. https://doi.org/10.1586/14737159.6.2.179
Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk Profiling
Journal of General Internal Medicine / Feb 11, 2011
Haga, S. B., Carrig, M. M., O’Daniel, J. M., Orlando, L. A., Killeya-Jones, L. A., Ginsburg, G. S., & Cho, A. (2011). Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk Profiling. Journal of General Internal Medicine, 26(8), 834–840. https://doi.org/10.1007/s11606-011-1651-7
Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding
Genome Medicine / Jul 31, 2014
Haga, S. B., Mills, R., Pollak, K. I., Rehder, C., Buchanan, A. H., Lipkus, I. M., Crow, J. H., & Datto, M. (2014). Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding. Genome Medicine, 6(7). https://doi.org/10.1186/s13073-014-0058-6
The potential impact of pharmacogenetic testing on medication adherence
The Pharmacogenomics Journal / Sep 03, 2013
Haga, S. B., & LaPointe, N. M. A. (2013). The potential impact of pharmacogenetic testing on medication adherence. The Pharmacogenomics Journal, 13(6), 481–483. https://doi.org/10.1038/tpj.2013.33
BP1, a Homeodomain-Containing Isoform of DLX4, Represses the β-Globin Gene
Molecular and Cellular Biology / Apr 01, 2002
Chase, M. B., Fu, S., Haga, S. B., Davenport, G., Stevenson, H., Do, K., Morgan, D., Mah, A. L., & Berg, P. E. (2002). BP1, a Homeodomain-Containing Isoform of DLX4, Represses the β-Globin Gene. Molecular and Cellular Biology, 22(8), 2505–2514. https://doi.org/10.1128/mcb.22.8.2505-2514.2002
Pharmacogenetic testing: not as simple as it seems
Genetics in Medicine / Jun 01, 2008
Haga, S. B., & Burke, W. (2008). Pharmacogenetic testing: not as simple as it seems. Genetics in Medicine, 10(6), 391–395. https://doi.org/10.1097/gim.0b013e31817701d4
Managing incidental genomic findings: legal obligations of clinicians
Genetics in Medicine / Aug 01, 2013
Clayton, E. W., Haga, S., Kuszler, P., Bane, E., Shutske, K., & Burke, W. (2013). Managing incidental genomic findings: legal obligations of clinicians. Genetics in Medicine, 15(8), 624–629. https://doi.org/10.1038/gim.2013.7
Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings
Genetic Testing and Molecular Biomarkers / Mar 01, 2012
Haga, S. B., Tindall, G., & O’Daniel, J. M. (2012). Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings. Genetic Testing and Molecular Biomarkers, 16(3), 193–197. https://doi.org/10.1089/gtmb.2011.0118
Public Perspectives Regarding Data-Sharing Practices in Genomics Research
Public Health Genomics / Jan 01, 2011
Haga, S. B., & O’Daniel, J. (2011). Public Perspectives Regarding Data-Sharing Practices in Genomics Research. Public Health Genomics, 14(6), 319–324. Portico. https://doi.org/10.1159/000324705
FDA Races in Wrong Direction
Science / Jul 25, 2003
Haga, S. B., & Venter, J. C. (2003). FDA Races in Wrong Direction. Science, 301(5632), 466–466. https://doi.org/10.1126/science.1087004
Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings
Genetic Testing and Molecular Biomarkers / Jan 01, 2012
Haga, S. B., Tindall, G., & O’Daniel, J. M. (2012). Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings. Genetic Testing and Molecular Biomarkers, 16(1), 21–24. https://doi.org/10.1089/gtmb.2011.0045
Using Pharmacogenetics to Improve Drug Safety and Efficacy
JAMA / Jun 16, 2004
Haga, S. B. (2004). Using Pharmacogenetics to Improve Drug Safety and Efficacy. JAMA, 291(23), 2869. https://doi.org/10.1001/jama.291.23.2869
Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing
Clinical Genetics / Feb 19, 2012
Haga, S., O’Daniel, J., Tindall, G., Mills, R., Lipkus, I., & Agans, R. (2012). Survey of genetic counselors and clinical geneticists’ use and attitudes toward pharmacogenetic testing. Clinical Genetics, 82(2), 115–120. Portico. https://doi.org/10.1111/j.1399-0004.2012.01848.x
Adding pharmacogenetics information to drug labels: lessons learned
Pharmacogenetics and Genomics / Dec 01, 2006
Haga, S. B., Thummel, K. E., & Burke, W. (2006). Adding pharmacogenetics information to drug labels: lessons learned. Pharmacogenetics and Genomics, 16(12), 847–854. https://doi.org/10.1097/01.fpc.0000236322.88433.ac
Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the β-globin gene
Gene / Oct 01, 2001
Fu, S., Stevenson, H., Strovel, J. W., Haga, S. B., Stamberg, J., Do, K., & Berg, P. E. (2001). Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the β-globin gene. Gene, 278(1–2), 131–139. https://doi.org/10.1016/s0378-1119(01)00716-8
Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing
Health Affairs / May 01, 2018
Haga, S. B., & Kantor, A. (2018). Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing. Health Affairs, 37(5), 717–723. https://doi.org/10.1377/hlthaff.2017.1564
Comparison of delivery strategies for pharmacogenetic testing services
Pharmacogenetics and Genomics / Mar 01, 2014
Haga, S. B., & Moaddeb, J. (2014). Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenetics and Genomics, 24(3), 139–145. https://doi.org/10.1097/fpc.0000000000000028
Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions
Genetics in Medicine / Aug 01, 2011
Haga, S. B., O’Daniel, J. M., Tindall, G. M., Lipkus, I. R., & Agans, R. (2011). Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions. Genetics in Medicine, 13(8), 723–728. https://doi.org/10.1097/gim.0b013e31821afcc0
Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design
BMC Health Services Research / Jan 18, 2012
Cho, A. H., Killeya-Jones, L. A., O’Daniel, J. M., Kawamoto, K., Gallagher, P., Haga, S., Lucas, J. E., Trujillo, G. M., Joy, S. V., & Ginsburg, G. S. (2012). Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. BMC Health Services Research, 12(1). https://doi.org/10.1186/1472-6963-12-16
Community pharmacists’ experience with pharmacogenetic testing
Journal of the American Pharmacists Association / Nov 01, 2015
Moaddeb, J., Mills, R., & Haga, S. B. (2015). Community pharmacists’ experience with pharmacogenetic testing. Journal of the American Pharmacists Association, 55(6), 587–594. https://doi.org/10.1331/japha.2015.15017
Patient experiences with pharmacogenetic testing in a primary care setting
Pharmacogenomics / Oct 01, 2016
Haga, S. B., Mills, R., Moaddeb, J., Allen Lapointe, N., Cho, A., & Ginsburg, G. S. (2016). Patient experiences with pharmacogenetic testing in a primary care setting. Pharmacogenomics, 17(15), 1629–1636. https://doi.org/10.2217/pgs-2016-0077
Pharmacogenetic testing: current evidence of clinical utility
Therapeutic Advances in Drug Safety / May 02, 2013
Moaddeb, J., & Haga, S. B. (2013). Pharmacogenetic testing: current evidence of clinical utility. Therapeutic Advances in Drug Safety, 4(4), 155–169. https://doi.org/10.1177/2042098613485595
Teaching resources for genetics
Nature Reviews Genetics / Feb 07, 2006
Haga, S. B. (2006). Teaching resources for genetics. Nature Reviews Genetics, 7(3), 223–229. https://doi.org/10.1038/nrg1803
Delivering pharmacogenetic testing in a primary care setting
Pharmacogenomics and Personalized Medicine / Sep 01, 2013
Mills, R., Voora, D., Peyser, B., & Haga, S. (2013). Delivering pharmacogenetic testing in a primary care setting. Pharmacogenomics and Personalized Medicine, 105. https://doi.org/10.2147/pgpm.s50598
Incorporation of pharmacogenetic testing into medication therapy management
Pharmacogenomics / Nov 01, 2015
Haga, S. B., Moaddeb, J., Mills, R., Patel, M., Kraus, W., & Allen LaPointe, N. M. (2015). Incorporation of pharmacogenetic testing into medication therapy management. Pharmacogenomics, 16(17), 1931–1941. https://doi.org/10.2217/pgs.15.124
Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings
Circulation: Genomic and Precision Medicine / Sep 01, 2018
Peyser, B., Perry, E. P., Singh, K., Gill, R. D., Mehan, M. R., Haga, S. B., Musty, M. D., Milazzo, N. A., Savard, D., Li, Y.-J., Trujilio, G., & Voora, D. (2018). Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings. Circulation: Genomic and Precision Medicine, 11(9). https://doi.org/10.1161/circgen.118.002228
Researcher Practices on Returning Genetic Research Results
Genetic Testing and Molecular Biomarkers / Dec 01, 2010
Heaney, C., Tindall, G., Lucas, J., & Haga, S. B. (2010). Researcher Practices on Returning Genetic Research Results. Genetic Testing and Molecular Biomarkers, 14(6), 821–827. https://doi.org/10.1089/gtmb.2010.0066
EDITORIAL BOARD
Race Ethnicity and Education / Nov 01, 2012
EDITORIAL BOARD. (2012). Race Ethnicity and Education, 15(5), ebi-ebi. https://doi.org/10.1080/13613324.2012.736166
Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
Journal of Personalized Medicine / Mar 27, 2014
Li, J., Joy, S., Haga, S., Orlando, L., Kraus, W., Ginsburg, G., & Voora, D. (2014). Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients. Journal of Personalized Medicine, 4(2), 147–162. https://doi.org/10.3390/jpm4020147
Defining the spectrum of genome policy
Nature Reviews Genetics / Dec 01, 2006
Haga, S. B., & Willard, H. F. (2006). Defining the spectrum of genome policy. Nature Reviews Genetics, 7(12), 966–972. https://doi.org/10.1038/nrg2003
Genomic Counseling: Next Generation Counseling
Journal of Genetic Counseling / Sep 12, 2013
Mills, R., & Haga, S. B. (2013). Genomic Counseling: Next Generation Counseling. Journal of Genetic Counseling, 23(4), 689–692. Portico. https://doi.org/10.1007/s10897-013-9641-z
Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population
Public Health Genomics / May 04, 2009
O’Daniel, J., Lucas, J., Deverka, P., Ermentrout, D., Silvey, G., Lobach, D. F., & Haga, S. B. (2009). Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population. Public Health Genomics, 13(1), 48–54. Portico. https://doi.org/10.1159/000217795
Binding of HMG-I(Y) elicits structural changes in a silencer of the human ?-globin gene
American Journal of Hematology / Jan 01, 1999
Chase, M. B., Haga, S. B., Hankins, W. D., Williams, D. M., Bi, Z., Strovel, J. W., Obriecht, C., & Berg, P. E. (1999). Binding of HMG-I(Y) elicits structural changes in a silencer of the human ?-globin gene. American Journal of Hematology, 60(1), 27–35. https://doi.org/10.1002/(sici)1096-8652(199901)60:1<27::aid-ajh6>3.0.co;2-0
Access to Genetic Counselors in the Southern United States
Journal of Personalized Medicine / Jul 01, 2019
Villegas, C., & Haga, S. B. (2019). Access to Genetic Counselors in the Southern United States. Journal of Personalized Medicine, 9(3), 33. https://doi.org/10.3390/jpm9030033
Primary-care physicians’ access to genetic specialists: an impediment to the routine use of genomic medicine?
Genetics in Medicine / Jul 01, 2013
Haga, S. B., Burke, W., & Agans, R. (2013). Primary-care physicians’ access to genetic specialists: an impediment to the routine use of genomic medicine? Genetics in Medicine, 15(7), 513–514. https://doi.org/10.1038/gim.2012.168
Challenges of development and implementation of point of care pharmacogenetic testing
Expert Review of Molecular Diagnostics / Jul 22, 2016
Haga, S. B. (2016). Challenges of development and implementation of point of care pharmacogenetic testing. Expert Review of Molecular Diagnostics, 16(9), 949–960. https://doi.org/10.1080/14737159.2016.1211934
Impact of Delivery Models on Understanding Genomic Risk for Type 2 Diabetes
Public Health Genomics / Jan 01, 2014
Haga, S. B., Barry, W. T., Mills, R., Svetkey, L., Suchindran, S., Willard, H. F., & Ginsburg, G. S. (2014). Impact of Delivery Models on Understanding Genomic Risk for Type 2 Diabetes. Public Health Genomics, 17(2), 95–104. Portico. https://doi.org/10.1159/000358413
Considerations for the Impact of Personal Genome Information: A Study of Genomic Profiling among Genetics and Genomics Professionals
Journal of Genetic Counseling / Mar 30, 2010
O’Daniel, J. M., Haga, S. B., & Willard, H. F. (2010). Considerations for the Impact of Personal Genome Information: A Study of Genomic Profiling among Genetics and Genomics Professionals. Journal of Genetic Counseling, 19(4), 387–401. Portico. https://doi.org/10.1007/s10897-010-9297-x
Pharmacogenomics courses in pharmacy school curricula
Pharmacogenomics / Jun 01, 2019
Haga, S. B., & Moaddeb, J. (2019). Pharmacogenomics courses in pharmacy school curricula. Pharmacogenomics, 20(9), 625–630. https://doi.org/10.2217/pgs-2019-0024
Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting
Pharmacogenomics / Sep 01, 2014
Haga, S. B., Allen LaPointe, N. M., Cho, A., Reed, S. D., Mills, R., Moaddeb, J., & Ginsburg, G. S. (2014). Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting. Pharmacogenomics, 15(13), 1677–1686. https://doi.org/10.2217/pgs.14.109
Challenges to Integrating Pharmacogenetic Testing into Medication Therapy Management
Journal of Managed Care & Specialty Pharmacy / Apr 01, 2015
Haga, S. B., LaPointe, N. M. A., & Moaddeb, J. (2015). Challenges to Integrating Pharmacogenetic Testing into Medication Therapy Management. Journal of Managed Care & Specialty Pharmacy, 21(4), 346–352. https://doi.org/10.18553/jmcp.2015.21.4.346
A stepwise approach to implementing pharmacogenetic testing in the primary care setting
Pharmacogenomics / Oct 01, 2019
Weitzel, K. W., Duong, B. Q., Arwood, M. J., Owusu-Obeng, A., Abul-Husn, N. S., Bernhardt, B. A., Decker, B., Denny, J. C., Dietrich, E., Gums, J., Madden, E. B., Pollin, T. I., Wu, R. R., Haga, S. B., & Horowitz, C. R. (2019). A stepwise approach to implementing pharmacogenetic testing in the primary care setting. Pharmacogenomics, 20(15), 1103–1112. https://doi.org/10.2217/pgs-2019-0053
Striking a balance in communicating pharmacogenetic test results: Promoting comprehension and minimizing adverse psychological and behavioral response
Patient Education and Counseling / Oct 01, 2014
Haga, S. B., Mills, R., & Bosworth, H. (2014). Striking a balance in communicating pharmacogenetic test results: Promoting comprehension and minimizing adverse psychological and behavioral response. Patient Education and Counseling, 97(1), 10–15. https://doi.org/10.1016/j.pec.2014.06.007
Primary care providers’ use of pharmacist support for delivery of pharmacogenetic testing
Pharmacogenomics / Mar 01, 2017
Haga, S. B., Mills, R., Moaddeb, J., Allen LaPointe, N., Cho, A., & Ginsburg, G. S. (2017). Primary care providers’ use of pharmacist support for delivery of pharmacogenetic testing. Pharmacogenomics, 18(4), 359–367. https://doi.org/10.2217/pgs-2016-0177
The Potential of a Placebo/Nocebo Effect in Pharmacogenetics
Public Health Genomics / Jan 01, 2009
Haga, S. B., Warner, L. R., & O’Daniel, J. (2009). The Potential of a Placebo/Nocebo Effect in Pharmacogenetics. Public Health Genomics, 12(3), 158–162. Portico. https://doi.org/10.1159/000189628
Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results
Genetics in Medicine / Oct 01, 2011
Haga, S. B., Kawamoto, K., Agans, R., & Ginsburg, G. S. (2011). Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results. Genetics in Medicine, 13(10), 887–890. https://doi.org/10.1097/gim.0b013e31822077a5
Clinical Utilization of Pharmacogenetics in Psychiatry – Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry
Pharmacopsychiatry / Sep 11, 2019
Brown, L., Eum, S., Haga, S. B., Strawn, J. R., & Zierhut, H. (2019). Clinical Utilization of Pharmacogenetics in Psychiatry – Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry. Pharmacopsychiatry, 53(04), 162–173. https://doi.org/10.1055/a-0975-9595
Enhancing geneticists’ perspectives of the public through community engagement
Genetics in Medicine / Feb 01, 2012
O’Daniel, J. M., Rosanbalm, K. D., Boles, L., Tindall, G. M., Livingston, T. M., & Haga, S. B. (2012). Enhancing geneticists’ perspectives of the public through community engagement. Genetics in Medicine, 14(2), 243–249. https://doi.org/10.1038/gim.2011.29
Ethical Issues of Predictive Genetic Testing for Diabetes
Journal of Diabetes Science and Technology / Jul 01, 2009
Haga, S. B. (2009). Ethical Issues of Predictive Genetic Testing for Diabetes. Journal of Diabetes Science and Technology, 3(4), 781–788. https://doi.org/10.1177/193229680900300427
Development and Initial Assessment of a Patient Education Video about Pharmacogenetics
Journal of Personalized Medicine / May 25, 2017
Mills, R., Ensinger, M., Callanan, N., & Haga, S. (2017). Development and Initial Assessment of a Patient Education Video about Pharmacogenetics. Journal of Personalized Medicine, 7(2), 4. https://doi.org/10.3390/jpm7020004
A review of consent practices and perspectives for pharmacogenetic testing
Pharmacogenomics / Sep 01, 2016
Haga, S. B., & Mills, R. (2016). A review of consent practices and perspectives for pharmacogenetic testing. Pharmacogenomics, 17(14), 1595–1605. https://doi.org/10.2217/pgs-2016-0039
Information‐Seeking and Sharing Behavior Following Genomic Testing for Diabetes Risk
Journal of Genetic Counseling / Jun 14, 2014
Mills, R., Powell, J., Barry, W., & Haga, S. B. (2014). Information‐Seeking and Sharing Behavior Following Genomic Testing for Diabetes Risk. Journal of Genetic Counseling, 24(1), 58–66. Portico. https://doi.org/10.1007/s10897-014-9736-1
Evaluation of a pharmacogenetic educational toolkit for community pharmacists
Pharmacogenomics / Sep 01, 2016
Haga, S. B., Mills, R., & Moaddeb, J. (2016). Evaluation of a pharmacogenetic educational toolkit for community pharmacists. Pharmacogenomics, 17(14), 1491–1502. https://doi.org/10.2217/pgs-2016-0002
Pharmacogenetic information for patients on drug labels
Pharmacogenomics and Personalized Medicine / Oct 01, 2014
Mills, R., Haga, S., & Moaddeb, J. (2014). Pharmacogenetic information for patients on drug labels. Pharmacogenomics and Personalized Medicine, 297. https://doi.org/10.2147/pgpm.s67876
Stakeholder Views on Returning Research Results
Advances in Genetics / Jan 01, 2013
Haga, S. B., & Zhao, J. Q. (2013). Stakeholder Views on Returning Research Results. In Advances in Genetics (pp. 41–81). Elsevier. https://doi.org/10.1016/b978-0-12-407703-4.00002-5
Promoting Public Awareness and Engagement in Genome Sciences
Journal of Genetic Counseling / Feb 23, 2013
Haga, S. B., Rosanbalm, K. D., Boles, L., Tindall, G. M., Livingston, T. M., & O’Daniel, J. M. (2013). Promoting Public Awareness and Engagement in Genome Sciences. Journal of Genetic Counseling, 22(4), 508–516. Portico. https://doi.org/10.1007/s10897-013-9577-3
Pilot study: incorporation of pharmacogenetic testing in medication therapy management services
Pharmacogenomics / Nov 01, 2014
Haga, S. B., Allen LaPointe, N. M., Moaddeb, J., Mills, R., Patel, M., & Kraus, W. E. (2014). Pilot study: incorporation of pharmacogenetic testing in medication therapy management services. Pharmacogenomics, 15(14), 1729–1737. https://doi.org/10.2217/pgs.14.118
Awareness of family health history in a predominantly young adult population
PLOS ONE / Oct 25, 2019
Madhavan, S., Bullis, E., Myers, R., Zhou, C. J., Cai, E. M., Sharma, A., Bhatia, S., Orlando, L. A., & Haga, S. B. (2019). Awareness of family health history in a predominantly young adult population. PLOS ONE, 14(10), e0224283. https://doi.org/10.1371/journal.pone.0224283
Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing
Journal of Genetic Counseling / Aug 19, 2015
Arora, S., Haverfield, E., Richard, G., Haga, S. B., & Mills, R. (2015). Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing. Journal of Genetic Counseling, 25(2), 337–343. Portico. https://doi.org/10.1007/s10897-015-9876-y
Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs
Pharmacogenomics / Dec 01, 2010
Surh, L. C., Pacanowski, M. A., Haga, S. B., Hobbs, S., Lesko, L. J., Gottlieb, S., Papaluca-Amati, M., Patterson, S. D., Hughes, A. R., Kim, M.-J., Close, S. L., Mosteller, M., Zineh, I., Dechairo, B., & Cohen, N. A. (2010). Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs. Pharmacogenomics, 11(12), 1637–1647. https://doi.org/10.2217/pgs.10.138
Prescribing BiDil
Journal of the American College of Cardiology / Jul 01, 2006
Haga, S. B., & Ginsburg, G. S. (2006). Prescribing BiDil. Journal of the American College of Cardiology, 48(1), 12–14. https://doi.org/10.1016/j.jacc.2006.04.017
Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting
Pharmacogenomics / Mar 01, 2017
Haga, S. B., Moaddeb, J., Mills, R., & Voora, D. (2017). Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting. Pharmacogenomics, 18(4), 327–335. https://doi.org/10.2217/pgs-2016-0175
<p>Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges</p>
Pharmacogenomics and Personalized Medicine / Oct 01, 2019
Haga, S. B. (2019). <p>Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges</p> Pharmacogenomics and Personalized Medicine, Volume 12, 273–285. https://doi.org/10.2147/pgpm.s179172
Educating patients and providers through comprehensive pharmacogenetic test reports
Pharmacogenomics / Jul 01, 2017
Haga, S. B. (2017). Educating patients and providers through comprehensive pharmacogenetic test reports. Pharmacogenomics, 18(11), 1047–1050. https://doi.org/10.2217/pgs-2017-0088
Analysis of Educational Materials and Destruction/Opt-Out Initiatives for Storage and Use of Residual Newborn Screening Samples
Genetic Testing and Molecular Biomarkers / Oct 01, 2010
Haga, S. B. (2010). Analysis of Educational Materials and Destruction/Opt-Out Initiatives for Storage and Use of Residual Newborn Screening Samples. Genetic Testing and Molecular Biomarkers, 14(5), 587–592. https://doi.org/10.1089/gtmb.2010.0010
Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing
Pharmacogenomics and Personalized Medicine / Jul 01, 2021
Haga, S. B., Mills, R., Moaddeb, J., Liu, Y., & Voora, D. (2021). Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing. Pharmacogenomics and Personalized Medicine, Volume 14, 877–886. https://doi.org/10.2147/pgpm.s314972
Nurses’ communication of pharmacogenetic test results as part of discharge care
Pharmacogenomics / Mar 01, 2015
Haga, S. B., & Mills, R. (2015). Nurses’ communication of pharmacogenetic test results as part of discharge care. Pharmacogenomics, 16(3), 251–256. https://doi.org/10.2217/pgs.14.173
First Responder to Genomic Information: A Guide for Primary Care Providers
Molecular Diagnosis & Therapy / Jun 07, 2019
Haga, S. B. (2019). First Responder to Genomic Information: A Guide for Primary Care Providers. Molecular Diagnosis & Therapy, 23(4), 459–466. https://doi.org/10.1007/s40291-019-00407-z
Qualitative user evaluation of a revised pharmacogenetic educational toolkit
Pharmacogenomics and Personalized Medicine / Sep 01, 2018
Mills, R., & Haga, S. B. (2018). Qualitative user evaluation of a revised pharmacogenetic educational toolkit. Pharmacogenomics and Personalized Medicine, Volume 11, 139–146. https://doi.org/10.2147/pgpm.s169648
Integrating pharmacogenetic testing into primary care
Expert Review of Precision Medicine and Drug Development / Nov 02, 2017
Haga, S. B. (2017). Integrating pharmacogenetic testing into primary care. Expert Review of Precision Medicine and Drug Development, 2(6), 327–336. https://doi.org/10.1080/23808993.2017.1398046
The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
Journal of Personalized Medicine / Jan 14, 2021
Kantor, A., & Haga, S. B. (2021). The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine. Journal of Personalized Medicine, 11(1), 45. https://doi.org/10.3390/jpm11010045
Toward digital-based interventions for medication adherence and safety
Expert Opinion on Drug Safety / May 22, 2020
Haga, S. B. (2020). Toward digital-based interventions for medication adherence and safety. Expert Opinion on Drug Safety, 19(6), 735–746. https://doi.org/10.1080/14740338.2020.1764935
Ensuring the Safe Use of Genomic Medicine in Children
Clinical Pediatrics / May 15, 2009
Haga, S. B., & Terry, S. F. (2009). Ensuring the Safe Use of Genomic Medicine in Children. Clinical Pediatrics, 48(7), 703–708. https://doi.org/10.1177/0009922809335736
Evaluating Primary Care Providers’ Readiness for Delivering Genetic and Genomic Services to Underserved Populations
Public Health Genomics / Sep 07, 2021
Sharma, Y., Cox, L., Kruger, L., Channamsetty, V., & Haga, S. B. (2021). Evaluating Primary Care Providers’ Readiness for Delivering Genetic and Genomic Services to Underserved Populations. Public Health Genomics, 25(1–2), 12–21. Portico. https://doi.org/10.1159/000518415
Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform
Applied Clinical Informatics / Mar 01, 2019
Wu, R., Myers, R., Buchanan, A., Dimmock, D., Fulda, K., Haller, I., Haga, S., Harry, M., McCarty, C., Neuner, J., Rakhra-Burris, T., Sperber, N., Voils, C., Ginsburg, G., & Orlando, L. (2019). Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform. Applied Clinical Informatics, 10(02), 180–188. https://doi.org/10.1055/s-0039-1679926
Introducing personalized health for the family: the experience of a single hospital system
Pharmacogenomics / Nov 01, 2017
Huddleston, K. L., Klein, E., Fuller, A., Jo, G., Lawrence, G., & Haga, S. B. (2017). Introducing personalized health for the family: the experience of a single hospital system. Pharmacogenomics, 18(17), 1589–1594. https://doi.org/10.2217/pgs-2017-0112
Patient Beliefs and Behaviors About Genomic Risk for Type 2 Diabetes: Implications for Prevention
Journal of Health Communication / Apr 06, 2015
Gallagher, P., King, H. A., Haga, S. B., Orlando, L. A., Joy, S. V., Trujillo, G. M., Scott, W. M., Bembe, M., Creighton, D. L., Cho, A. H., Ginsburg, G. S., & Vorderstrasse, A. (2015). Patient Beliefs and Behaviors About Genomic Risk for Type 2 Diabetes: Implications for Prevention. Journal of Health Communication, 20(6), 728–735. https://doi.org/10.1080/10810730.2015.1018563
A Systematic Review of the Scope of Study of mHealth Interventions for Wellness and Related Challenges in Pediatric and Young Adult Populations
Adolescent Health, Medicine and Therapeutics / Feb 01, 2022
Bond, S. J., Parikh, N., Majmudar, S., Pin, S., Wang, C., Willis, L., & Haga, S. B. (2022). A Systematic Review of the Scope of Study of mHealth Interventions for Wellness and Related Challenges in Pediatric and Young Adult Populations. Adolescent Health, Medicine and Therapeutics, Volume 13, 23–38. https://doi.org/10.2147/ahmt.s342811
Revisiting Secondary Information Related to Pharmacogenetic Testing
Frontiers in Genetics / Oct 01, 2021
Haga, S. B. (2021). Revisiting Secondary Information Related to Pharmacogenetic Testing. Frontiers in Genetics, 12. https://doi.org/10.3389/fgene.2021.741395
The enduring importance of family health history in the era of genomic medicine and risk assessment
Personalized Medicine / May 01, 2020
Haga, S. B., & Orlando, L. A. (2020). The enduring importance of family health history in the era of genomic medicine and risk assessment. Personalized Medicine, 17(3), 229–239. https://doi.org/10.2217/pme-2019-0091
Update: looking beyond the 100,000 Genome Project
Personalized Medicine / Mar 01, 2017
Haga, S. B. (2017). Update: looking beyond the 100,000 Genome Project. Personalized Medicine, 14(2), 85–87. https://doi.org/10.2217/pme-2016-0101
Comparative Effectiveness Research and Demonstrating Clinical Utility for Molecular Diagnostic Tests
Clinical Chemistry / Jan 01, 2015
Deverka, P. A., & Haga, S. B. (2015). Comparative Effectiveness Research and Demonstrating Clinical Utility for Molecular Diagnostic Tests. Clinical Chemistry, 61(1), 142–144. https://doi.org/10.1373/clinchem.2014.223412
Delivering pharmacogenetic testing to the masses: an achievable goal?
Pharmacogenomics / Jan 01, 2014
Haga, S. B. (2014). Delivering pharmacogenetic testing to the masses: an achievable goal? Pharmacogenomics, 15(1), 1–4. https://doi.org/10.2217/pgs.13.211
Genetic Testing: Clinical and Personal Utility
AMA Journal of Ethics / Aug 01, 2012
Genetic Testing: Clinical and Personal Utility. (2012). AMA Journal of Ethics, 14(8), 604–609. https://doi.org/10.1001/virtualmentor.2012.14.8.ecas1-1208
Practical Ethics: Establishing a Pathway to Benefit for Complex Pharmacogenomic Tests
Clinical Pharmacology & Therapeutics / Jul 01, 2011
Haga, S. B., & Burke, W. (2011). Practical Ethics: Establishing a Pathway to Benefit for Complex Pharmacogenomic Tests. Clinical Pharmacology & Therapeutics, 90(1), 25–27. https://doi.org/10.1038/clpt.2011.71
Letting the Genome Out of the Bottle
New England Journal of Medicine / May 15, 2008
Letting the Genome Out of the Bottle. (2008). New England Journal of Medicine, 358(20), 2184–2185. https://doi.org/10.1056/nejmc086053
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
Pharmacy / Sep 10, 2023
Haga, S. B. (2023). The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S. Pharmacy, 11(5), 144. https://doi.org/10.3390/pharmacy11050144
Expanding Family Health History to Include Family Medication History
Journal of Personalized Medicine / Feb 25, 2023
Haga, S. B., & Orlando, L. A. (2023). Expanding Family Health History to Include Family Medication History. Journal of Personalized Medicine, 13(3), 410. https://doi.org/10.3390/jpm13030410
Education
University of Maryland, Baltimore
PhD, Human Genetics / May, 1999
Experience
School of Medicine, Duke University
Professor
Links & Social Media
Join Susanne on NotedSource!
Join Now
At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.
For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.
For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.
Expert Institutions
![NotedSource has experts from Stanford University](/img/logo-stanford.png)
![Expert institutions using NotedSource include Oxfort University](/img/logo-oxford.webp)
![Experts from McGill have used NotedSource to share their expertise](/img/logo-mcgill.webp)
![MIT researchers have used NotedSource](/img/logo-mit.webp)
Proudly trusted by
![Microsoft uses NotedSource for academic partnerships](/img/logo-microsoft.webp)
![Johnson & Johnson academic research projects on NotedSource](/img/logo-johnson-and-johnson.webp)
![ProQuest (Clarivate) uses NotedSource as their industry academia platform](/img/logo-proquest.png)
![Slamom consulting engages academics for research collaboration on NotedSource](/img/logo-slalom.png)
![Omnicom and OMG find academics on notedsource](/img/logo-omnicom-group.png)
![Unilever research project have used NotedSource to engage academic experts](/img/logo-unilever.png)